LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada

Recruiting Observational Study
Lung Neoplasms
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 130
Sex
Any
Study type
Observational
Participants needed
60,000 (estimated)
Sponsor
AstraZeneca · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

LUNG-ROLL is a retrospective cohort study that will describe the contemporary treatment patterns, prevalence and incidence, patient demographic and clinical characteristics, clinical outcomes, and healthcare resource use/costs for patients with lung cancer in Canada (specifically, Alberta and Ontario) using administrative data.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients with lung cancer between January 1, 2018 and end of the Selection Period. * Patient is 18 years of age or older on diagnosis date. * Patient has at least 12 months of health insurance coverage prior to the diagnosis date. Exclusion Criteria: * Diagnosed with any oth…
Contacts

AstraZeneca Clinical Study Information Center

1-877-240-9479

information.center@astrazeneca.com

CONTACT